Third Harmonic Bio, Inc.
THRD · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | -$0 | $0 | -$0 | -$0 |
| % Margin | – | 50% | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -34,220.8% | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -27,306.3% | – | – |
| EPS Diluted | -0.35 | -0.29 | 0.33 | -0.26 |
| % Growth | -20.7% | -187.9% | 226.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |